22 related articles for article (PubMed ID: 1963183)
1. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.
Wong GW; Boyda HN; Wright JM
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007451. PubMed ID: 26961574
[TBL] [Abstract][Full Text] [Related]
3. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
Myburgh DP; Gordon NF
Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
[TBL] [Abstract][Full Text] [Related]
4. Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients.
Chrysant SG; Miller E
Clin Cardiol; 1994 Dec; 17(12):670-4. PubMed ID: 7867240
[TBL] [Abstract][Full Text] [Related]
5. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
[TBL] [Abstract][Full Text] [Related]
6. Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination.
Wing LM; Chalmers JP; West MJ; Russell AE; Morris MJ; Cain MD; Bune AJ; Southgate DO
Clin Exp Hypertens A; 1988; 10(1):119-33. PubMed ID: 2832102
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions.
Wing LM; Chalmers JP; West MJ; Bune AJ; Russell AE; Elliott JM; Morris MJ
J Hypertens Suppl; 1987 Dec; 5(5):S603-6. PubMed ID: 2832575
[TBL] [Abstract][Full Text] [Related]
8. Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy.
Tonkin AL; Wing LM; Russell AE; West MJ; Bune AJ; Morris MJ; Cain MD; Chalmers J
J Hypertens; 1990 Nov; 8(11):1015-9. PubMed ID: 1963183
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
10. Cardiac conduction with diltiazem and beta-blockade combined. A review and report on cases.
Kjeldsen SE; Syvertsen JO; Hedner T
Blood Press; 1996 Sep; 5(5):260-3. PubMed ID: 8879597
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
